Cargando…

Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study

Nonalcoholic fatty liver disease (NAFLD) is known as a risk of incident cardiovascular disease (CVD). About 20% of NAFLD occurs in nonobese individuals. However, it remains to be elucidated the association between nonoverweight with NAFLD and a risk of incident CVD. Therefore, we investigated the ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshitaka, Hashimoto, Hamaguchi, Masahide, Kojima, Takao, Fukuda, Takuya, Ohbora, Akihiro, Fukui, Michiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419911/ https://www.ncbi.nlm.nih.gov/pubmed/28471965 http://dx.doi.org/10.1097/MD.0000000000006712

Ejemplares similares

A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men
por: Nakanishi, Naoko, et al.
Publicado: (2021)

The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
por: Kitae, Aya, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease remission in men through regular exercise
por: Osaka, Takafumi, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal study
por: Hamaguchi, Masahide, et al.
Publicado: (2019)

Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study
por: Okamura, Takuro, et al.
Publicado: (2020)

Metabolic associated fatty liver disease is a risk factor for chronic kidney disease
por: Hashimoto, Yoshitaka, et al.
Publicado: (2021)

Association between serum γ-glutamyltranspeptidase and atherosclerosis: a population-based cross-sectional study
por: Fukuda, Takuya, et al.
Publicado: (2014)

Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study
por: Hamaguchi, Masahide, et al.
Publicado: (2020)

Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
por: Okamura, Takuro, et al.
Publicado: (2021)

Impact of metabolically healthy obesity on the risk of incident gastric cancer: a population-based cohort study
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Creatinine to Body Weight Ratio Is Associated with Incident Diabetes: Population-Based Cohort Study
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Visceral Adiposity Index is a predictor of incident colorectal cancer: a population-based longitudinal study
por: Okamura, Takuro, et al.
Publicado: (2020)

Triglyceride–glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study
por: Okamura, Takuro, et al.
Publicado: (2020)

Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
por: Yoshimura, Yuta, et al.
Publicado: (2021)

Reduction of Fat to Muscle Mass Ratio Is Associated with Improvement of Liver Stiffness in Diabetic Patients with Non-Alcoholic Fatty Liver Disease
por: Osaka, Takafumi, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
por: Sinn, Dong Hyun, et al.
Publicado: (2016)

Risk factors of nonalcoholic fatty liver disease in healthy women
por: Guan, Hui, et al.
Publicado: (2023)

Microbe‐associated metabolites as targets for incident type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Nonalcoholic fatty liver disease is associated with both subcutaneous and visceral adiposity: A cross-sectional study
por: Kure, Takeshi, et al.
Publicado: (2019)

Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease
por: Kawaguchi, Kazunori, et al.
Publicado: (2021)

Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis
por: Zhou, Xiangyu, et al.
Publicado: (2023)

Development of de novo nonalcoholic fatty liver disease following pancreatectomy
por: Patel, Vanisha, et al.
Publicado: (2023)

The metabolic influence of duodenal mucosal resurfacing for nonalcoholic fatty liver disease
por: Chuang, Te-Jung, et al.
Publicado: (2023)

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
por: Huang, Xiaolin, et al.
Publicado: (2015)

Reversal of nonalcoholic fatty liver disease reduces the risk of cardiovascular disease among Korean
por: Oh, Yun Hwan, et al.
Publicado: (2023)

Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
por: Romero-Gomez, Manuel, et al.
Publicado: (2020)

Association of resting heart rate with nonalcoholic fatty liver disease in postmenopausal women
por: Kim, Hong-Bae, et al.
Publicado: (2020)

A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease
por: Peng, Kaili, et al.
Publicado: (2021)

The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease: A Negative Risk Factor for Colorectal Cancer Prognosis
por: You, Jie, et al.
Publicado: (2015)

Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
por: Golabi, Pegah, et al.
Publicado: (2018)

Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis
por: Qi, Shan, et al.
Publicado: (2017)

Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins
por: Pirola, Carlos J., et al.
Publicado: (2015)

The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease
por: Liang, Jing, et al.
Publicado: (2016)

Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients
por: Phisalprapa, Pochamana, et al.
Publicado: (2017)

Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients
por: Saokaew, Surasak, et al.
Publicado: (2020)

Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Xiong, Pian, et al.
Publicado: (2021)

Association between nonalcoholic fatty liver disease and colorectal cancer: A population-based study
por: Wu, Po-Hsien, et al.
Publicado: (2023)

Statins on nonalcoholic fatty liver disease: A systematic review and meta-analysis of 14 RCTs
por: Zhou, Haiyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1k0iuu246dnu6iu5731qpfa2ud